Vector BioPharma
Basel
About Vector BioPharma
Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $30.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2022)
- Website: vectorbiopharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/vector-biopharma-20547 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.